Cargando…
Traumatic brain injury and mood disorders
Traumatic brain injury is an increasing cause of morbidity worldwide. Neuropsychiatric impairments, such as behavioral dysregulation and depression, have significant impacts on recovery, functional outcomes, and quality of life of patients with traumatic brain injuries. Three patient cases, existing...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653730/ https://www.ncbi.nlm.nih.gov/pubmed/33224691 http://dx.doi.org/10.9740/mhc.2020.11.335 |
_version_ | 1783607931948761088 |
---|---|
author | Robert, Sophie |
author_facet | Robert, Sophie |
author_sort | Robert, Sophie |
collection | PubMed |
description | Traumatic brain injury is an increasing cause of morbidity worldwide. Neuropsychiatric impairments, such as behavioral dysregulation and depression, have significant impacts on recovery, functional outcomes, and quality of life of patients with traumatic brain injuries. Three patient cases, existing literature, and expert opinion are used to select pharmacotherapy for the treatment of target symptoms while balancing safety and tolerability. |
format | Online Article Text |
id | pubmed-7653730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | College of Psychiatric & Neurologic Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-76537302020-11-20 Traumatic brain injury and mood disorders Robert, Sophie Ment Health Clin Psychopharmacology Pearls Traumatic brain injury is an increasing cause of morbidity worldwide. Neuropsychiatric impairments, such as behavioral dysregulation and depression, have significant impacts on recovery, functional outcomes, and quality of life of patients with traumatic brain injuries. Three patient cases, existing literature, and expert opinion are used to select pharmacotherapy for the treatment of target symptoms while balancing safety and tolerability. College of Psychiatric & Neurologic Pharmacists 2020-11-05 /pmc/articles/PMC7653730/ /pubmed/33224691 http://dx.doi.org/10.9740/mhc.2020.11.335 Text en © 2020 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Psychopharmacology Pearls Robert, Sophie Traumatic brain injury and mood disorders |
title | Traumatic brain injury and mood disorders |
title_full | Traumatic brain injury and mood disorders |
title_fullStr | Traumatic brain injury and mood disorders |
title_full_unstemmed | Traumatic brain injury and mood disorders |
title_short | Traumatic brain injury and mood disorders |
title_sort | traumatic brain injury and mood disorders |
topic | Psychopharmacology Pearls |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653730/ https://www.ncbi.nlm.nih.gov/pubmed/33224691 http://dx.doi.org/10.9740/mhc.2020.11.335 |
work_keys_str_mv | AT robertsophie traumaticbraininjuryandmooddisorders |